The global Tuberculosis Vaccine Market is estimated to driven by Increasing incidence of drug-resistant TB cases
Tuberculosis (TB) vaccine development is witnessing rapid advancements driven by growing demand. Tuberculosis vaccines aim to provide protection against Mycobacterium tuberculosis, the bacteria that causes TB. As TB is a major cause of death worldwide and existing Bacillus Calmette-Guerin (BCG) vaccine provides limited protection, there is a huge clinical need for more effective TB vaccines....